Literature DB >> 12816877

Caveolin-1 can regulate vascular smooth muscle cell fate by switching platelet-derived growth factor signaling from a proliferative to an apoptotic pathway.

Timothy E Peterson1, Maria E Guicciardi, Rajiv Gulati, Laurel S Kleppe, Cheryl S Mueske, Martina Mookadam, Grzegorz Sowa, Gregory J Gores, William C Sessa, Robert D Simari.   

Abstract

BACKGROUND: Caveolin-1 is a regulator of signaling events originating from plasma membrane microdomains termed caveolae. This study was performed to determine the regulatory role of caveolin-1 on the proliferative events induced by platelet-derived growth factor (PDGF) in vascular smooth muscle cells (VSMCs). METHODS AND
RESULTS: Treatment of VSMCs with PDGF for 24 hours resulted in a loss of caveolin-1 protein expression and plasma membrane-associated caveolae, despite a 3-fold increase in caveolin-1 mRNA. Pretreatment of VSMCs with chloroquine, an inhibitor of lysosomal function, inhibited the PDGF-induced loss of caveolin-1. These studies demonstrated that caveolin-1 was a target of PDGF signaling events. Adenoviral overexpression of caveolin-1 was associated with a switch in PDGF-induced signaling events from a proliferative response to an apoptotic response. This overexpression inhibited PDGF-induced expression of cyclin D1 in the presence of unaffected mitogen-activated protein kinase activation.
CONCLUSIONS: Taken together, these studies suggest that caveolin-1 is an inhibitor of PDGF proliferative responses and might be capable of transforming PDGF-induced proliferative signals into death signals.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12816877     DOI: 10.1161/01.ATV.0000081743.35125.05

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  33 in total

1.  Maternal nutrient restriction alters gene expression in the ovine fetal heart.

Authors:  Hyung-Chul Han; Kathleen J Austin; Peter W Nathanielsz; Stephen P Ford; Mark J Nijland; Thomas R Hansen
Journal:  J Physiol       Date:  2004-05-07       Impact factor: 5.182

2.  Renal caveolin-1 expression in children with unilateral ureteropelvic junction obstruction.

Authors:  Patricia G Vallés; Walter Manucha; Liliana Carrizo; José Vega Perugorria; Alicia Seltzer; Celeste Ruete
Journal:  Pediatr Nephrol       Date:  2006-11-17       Impact factor: 3.714

3.  Distribution of caveolin-1 and connexin43 in normal and injured alveolar epithelial R3/1 cells.

Authors:  K Barth; M Gentsch; R Bläsche; A Pfüller; I Parshyna; R Koslowski; G Barth; M Kasper
Journal:  Histochem Cell Biol       Date:  2004-11-20       Impact factor: 4.304

4.  Age-related focal loss of contractile vascular smooth muscle cells in retinal arterioles is accelerated by caveolin-1 deficiency.

Authors:  Alaina M Reagan; Xiaowu Gu; Sijalu Paudel; Nicole M Ashpole; Michelle Zalles; William E Sonntag; Zoltan Ungvari; Anna Csiszar; Laura Otalora; Willard M Freeman; Michael B Stout; Michael H Elliott
Journal:  Neurobiol Aging       Date:  2018-07-10       Impact factor: 4.673

5.  Understanding the metabolic basis of drug resistance: therapeutic induction of the Warburg effect kills cancer cells.

Authors:  Ubaldo E Martinez-Outschoorn; Zhao Lin; Ying-Hui Ko; Allison F Goldberg; Neal Flomenberg; Chenguang Wang; Stephanos Pavlides; Richard G Pestell; Anthony Howell; Federica Sotgia; Michael P Lisanti
Journal:  Cell Cycle       Date:  2011-08-01       Impact factor: 4.534

6.  Genetic risk factors for portopulmonary hypertension in patients with advanced liver disease.

Authors:  Kari E Roberts; Michael B Fallon; Michael J Krowka; Robert S Brown; James F Trotter; Inga Peter; Hocine Tighiouart; James A Knowles; Daniel Rabinowitz; Raymond L Benza; David B Badesch; Darren B Taichman; Evelyn M Horn; Steven Zacks; Neil Kaplowitz; Steven M Kawut
Journal:  Am J Respir Crit Care Med       Date:  2009-02-12       Impact factor: 21.405

7.  Insulin resistance in skeletal muscles of caveolin-3-null mice.

Authors:  Jin Oshikawa; Koji Otsu; Yoshiyuki Toya; Takashi Tsunematsu; Raleigh Hankins; Jun-ichi Kawabe; Susumu Minamisawa; Satoshi Umemura; Yasuko Hagiwara; Yoshihiro Ishikawa
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-16       Impact factor: 11.205

8.  Over-expression of caveolin-1 aggravate LPS-induced inflammatory response in AT-1 cells via up-regulation of cPLA2/p38 MAPK.

Authors:  Xue-Jun Lv; Yu-Ying Li; Yong-Juan Zhang; Mei Mao; Gui-Sheng Qian
Journal:  Inflamm Res       Date:  2010-01-23       Impact factor: 4.575

9.  Inflammatory cytokines induce caveolin-1/β-catenin signalling in rat nucleus pulposus cell apoptosis through the p38 MAPK pathway.

Authors:  Jianxi Wang; Huajiang Chen; Peng Cao; Xiaodong Wu; Fazhi Zang; Liangyu Shi; Lei Liang; Wen Yuan
Journal:  Cell Prolif       Date:  2016-04-29       Impact factor: 6.831

10.  Genomic variant in CAV1 increases susceptibility to coronary artery disease and myocardial infarction.

Authors:  Shanshan Chen; Xiaojing Wang; Junhan Wang; Yuanyuan Zhao; Dan Wang; Chengcheng Tan; Jingjing Fa; Rongfeng Zhang; Fan Wang; Chaoping Xu; Yufeng Huang; Sisi Li; Dan Yin; Xin Xiong; Xiuchun Li; Qiuyun Chen; Xin Tu; Yanzong Yang; Yonglong Xia; Chengqi Xu; Qing K Wang
Journal:  Atherosclerosis       Date:  2016-01-08       Impact factor: 5.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.